M. Docteur DENIS ARNIAUD
✨ Profil synthétique
IA · 29/04/2026Le Dr Denis Arniaud est un rhumatologue libéral à Marseille, auteur de 17 publications avec un h-index de 6. Ses recherches portent notamment sur la gestion de la douleur, les myopathies inflammatoires et les spondylarthropathies. Il a également mené des études sur les essais cliniques et les traitements anti-TNF.
Expertises présumées
- Spondylarthropathies
- Myopathies inflammatoires
- Dermatomyosite
- Gestion de la douleur
- Thérapies anti-TNF
- Essais cliniques
- Stimulation du nerf vague
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Thèses universitaires
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
6
h articles cités ≥ h fois chacun. Un h de 6 = 6 publications avec 6+ citations.
Citations
449
Publications
17
i10-index
5
Thématiques principales
- Pain Management and Treatment ×5
- Inflammatory Myopathies and Dermatomyositis ×4
- Vagus Nerve Stimulation Research ×4
- Laser Applications in Dentistry and Medicine ×3
- Spondyloarthritis Studies and Treatments ×2
Affiliations FR : Hôpital Saint Joseph
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
2021ArticleThe Lancet Rheumatology
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
2020ArticleAnnals of the Rheumatic Diseases
Single Injection of High Volume of Autologous Pure PRP Provides a Significant Improvement in Knee Osteoarthritis: A Prospective Routine Care Study
2019ArticleInternational Journal of Molecular Sciences
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Lieu de consultation
CABINET DU DR DENIS ARNIAUD
HOPITAL SAINT JOSEPH, SCE DE RHUMATOLOGIE — 26 BOULEVARD DE LOUVAIN, 13285 Marseille
☎ 0491806631Libéral
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Vidéos & interventions (1)
Source YouTube · recherche par nom (homonymes possibles).
Top publications · les plus citées
- 1Single Injection of High Volume of Autologous Pure PRP Provides a Significant Improvement in Knee Osteoarthritis: A Prospective Routine Care Study
International journal of molecular sciences · 2019
Lire l'abstract Crossref ↓
Background: Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure. Methods: Fifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria. Results: A single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure (p < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 (p < 0.001). No difference was observed on MRI parameters. Conclusion: A single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital.
- 2Sporotrichoid non-tuberculous mycobacterial infections following anti-TNF treatment
Medecine et maladies infectieuses · 2018
📚 2 citations - 3Aetiologies of male osteoporosis: identification procedures
Clinical rheumatology · 1993
📚 2 citations
Publications scientifiques (4) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal2
▼
Transversal2
▼- Single Injection of High Volume of Autologous Pure PRP Provides a Significant Improvement in Knee Osteoarthritis: A Prospective Routine Care Study
International journal of molecular sciences · 2019 · Journal Article
Guillibert C, Charpin C, Raffray M, Benmenni A, et al.
📚 42 cit.🎯 RCR 3.33🔬→🩺 Translationnel - Aetiologies of male osteoporosis: identification procedures
Clinical rheumatology · 1993 · Journal Article
Mattei JP, Arniaud D, Tonolli I, Roux H
📚 2 cit.
Anti-TNF1
▼
Anti-TNF1
▼- Sporotrichoid non-tuberculous mycobacterial infections following anti-TNF treatment
Medecine et maladies infectieuses · 2018 · Case Reports
Doudier B, Quiles-Tsimaratos N, Arniaud D
📚 2 cit.
Essai clinique1
▼
Essai clinique1
▼- Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial
The Lancet. Rheumatology · 2026 · Journal Article
Courties A, Tuffet S, Cormier G, Roux CH, et al.
🩺 Clinique

